Not yet recruiting
Immunisation+3
Not yet recruitingSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
Registered drug
SARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
Registered drug
- Disease:ImmunisationInfluenza immunisation+2
- Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATEDInfluenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated+5
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
- Sponsor:Sanofi Pasteur Inc.
